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The inﬁltration of red blood cells into atheromatous plaques is implicated in atherogenesis. Inside the lesion, hemoglobin (Hb) is
oxidized to ferri- and ferrylHb which exhibit prooxidant and proinﬂammatory activities. Cystathione gamma-lyase- (CSE-) derived
H2S has been suggested to possess various antiatherogenic actions. Expression of CSE was upregulated predominantly in
macrophages, foam cells, and myoﬁbroblasts of human atherosclerotic lesions derived from carotid artery specimens of patients.
A similar pattern was observed in aortic lesions of apolipoprotein E-deﬁcient mice on high-fat diet. We identiﬁed several
triggers for inducing CSE expression in macrophages and vascular smooth muscle cells including heme, ferrylHb, plaque lipids,
oxidized low-density lipoprotein, tumor necrosis factor-α, and interleukin-1β. In the interplay between hemoglobin and
atheroma lipids, H2S signiﬁcantly mitigated oxidation of Hb preventing the formation of ferrylHb derivatives, therefore
providing a novel function as a heme-redox-intermediate-scavenging antioxidant. By inhibiting Hb-lipid interactions, sulﬁde
lowered oxidized Hb-mediated induction of adhesion molecules in endothelium and disruption of endothelial integrity.
Exogenous H2S inhibited heme and Hb-mediated lipid oxidation of human atheroma-derived lipid and human complicated
lesion. Our study suggests that the CSE/H2S system represents an atheroprotective pathway for removing or limiting the
formation of oxidized Hb and lipid derivatives in the atherosclerotic plaque.
1. Introduction
Atherosclerosis-related morbidity and mortality are closely
associated with the presence of vulnerable plaques and com-
plicated lesions [1–3]. These lesions contain products of lipid
peroxidation such as lipid hydroperoxides, aldehydes and
carbonyls, calcium, and redox active iron [4]. Vascular
lesions are called complicated where due to a disruption of
the atheromatous plaque, inﬁltration of red blood cells
(RBCs) are visualized inside the lesion [2]. It was recently
shown by Michel et al. that the neovascularization could be
observed from the adventitia through the media into the
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plaque [5]. Often, RBCs inﬁltrate these lesions as a con-
sequence of leaky neovessels or intraplaque hemorrhage
[3, 6]. It was shown that part of the damaged RBCs are taken
up by macrophages via erythrophagocytosis and degraded in
the lysosome. The generated iron could be exocytosed from
the macrophages to the extracellular space and induce oxida-
tion of the LDL and its uptake by macrophages [7–9]. It was
shown that invading RBCs lyse and release hemoglobin (Hb)
inside the plaque and react with the surrounding plaque
lipids [10–12]. In the reactions between Hb and plaque lipids,
diﬀerent oxidized Hb derivatives are formed including
metHb (Fe3+) and ferrylHb (Fe4+=O2−) species [10–12].
Furthermore, the ferryl form is unstable and triggers an elec-
tron transfer from proximal amino acids of the globin chain
to iron, resulting in globin radical formation. Termination
reactions of globin radicals yield covalently cross-linked Hb
multimers which are present in human complicated athero-
sclerotic lesions [10, 12].
Oxidized Hb species exert diﬀerent prooxidant and pro-
inﬂammatory eﬀects. Both metHb and ferrylHb (we herein
use the term ferrylHb to refer to the sum of all those oxidized
Hb species in which production the unstable Fe4+ oxidation
state has been involved) sensitize vascular endothelial cells
to oxidant-mediated killing [11, 13] and induce lipid per-
oxidation via the release of heme and redox active iron
[11, 14]. Oxidized Hb has been recently shown to provoke
the rearrangement of F-actin cytoskeleton and subsequently
the formation of intercellular gaps in endothelium in vitro
and facilitate the adherence of monocytes to the endothelium
through the induction of adhesion molecules: vascular cell
adhesion molecule-1 (VCAM-1), intercellular adhesion
molecule-1 (ICAM-1), and E-selectin [11, 15].
Hydrogen sulﬁde (H2S), recently proposed as the newest
member of the gaseous mediators’ family, has been shown to
possess antiatherogenic eﬀects in diﬀerent animal models
(reviewed in [16]). Wang et al. previously reported that
atherosclerotic lesion formation is inhibited by sodium
hydrosulﬁde (NaSH, an inorganic source of sulﬁde) in apoli-
poprotein E knockout mice (ApoE−/−), whereas pharmaco-
logical inhibition of cystathionine gamma-lyase (CSE), a
key enzyme of H2S generation in the vasculature, resulted
in accelerated plaque formation [17]. A more recent and
robust study by Mani et al. using CSE knockout mice showed
decreased vascular production of H2S accompanied by
accelerated atherosclerotic plaque progression compared to
wild-type animal highlighting the central importance of
CSE and H2S as endogenous vasoprotective mediators [18].
Based on these observations, we aimed to investigate
whether hydrogen sulﬁde inhibits hemoglobin-lipid interac-
tions in atherosclerotic lesions and alter subsequent endothe-
lial cell reactions. We also determined how atherogenesis
inﬂuenced the vascular expression of CSE and identiﬁed
pathophysiological modulators of CSE expression.
2. Materials and Methods
2.1. Materials. All chemicals were analytical reagent grade
or better and purchased from Sigma-Aldrich (St. Louis,
MO, USA). The sulﬁde donor molecules used in this
study—GYY4137 (P-(4-methoxyphenyl)-P-4-morpholinyl-
phosphinodithioic acid morpholine salt), AP67 (4-methox-
yphenyl)(pyrrolidin-1-yl)phosphinodithioc acid), and AP72
(4-methoxyphenyl)(piperidin-1-yl)phosphinodithioc acid)—
were synthesized in-house [19, 20]. Sulﬁde stock solutions
were prepared fresh daily in water and used immediately.
2.2. Human Tissue Samples. For the study, we used 54 carotid
artery specimens collected from 54 human patients who
underwent carotid endarterectomy surgery. 15 samples were
used for immunohistochemistry analysis, and 39 carotid
arteries were used for the in vitro experiments. Written
informed consent was received from the participants accord-
ing to the Declaration of Helsinki. A pathologist examined
the samples and classiﬁed them according to AHA guide-
lines. Type I (healthy), IV (atheromatous), and VI (compli-
cated) lesions were selected for the study.
2.3. Mice. All the animal experiments were approved by
the guidelines from Directive 2010/63/EU of the European
Parliament on the protection of animals used for scientiﬁc
purposes. Animal experiments performed in this study were
approved by the Scientiﬁc and Research Ethics Committee
of the Scientiﬁc Council of Health of the Hungarian Govern-
ment under the registration number DE MÁB/157-5/2010
and are reported in accordance with the ARRIVE guidelines.
C57BL/6 ApoE−/− mice were maintained at the University of
Debrecen under speciﬁc pathogen-free conditions in accor-
dance with guidelines from Institutional Ethical Committee.
To induce atherosclerotic plaque formation, standard chow
diet was changed to atherogenic diet (15% fat, 1.25% cho-
lesterol, ssniﬀ-Spezialdiäten GmbH, Soest, Germany) at the
age of 8 weeks. Mice were randomly divided into three
groups, and parallel with the atherogenic diet, mice were
injected intraperitoneally with NaSH (56μmol/kg body
weight; N = 9), PPG (50mg/kg, N = 5), or vehicle (PBS;
N = 21) every other day as previously described [17]. Aortas
were harvested after 8 weeks of treatment. All mice were
euthanized by predictable and controllable administering
slow-ﬁll compressed CO2 asphyxiation.
2.4. Cell Culture. Human aortic endothelial cells (HAoECs)
(PromoCell, Heidelberg, Germany) were cultured in medium
199 containing 15% FBS, antibiotics, L-glutamine, sodium
pyruvate, and EC growth factor as described previously.
HAoECs were used at passages 2 and 3 within 2 days post-
conﬂuence. Human aortic smooth muscle cells (HASMCs)
(PromoCell, Heidelberg, Germany) were cultured in DMEM
supplemented with 10% FBS, L-glutamine, sodium pyruvate,
and antibiotics. RAW264.7 murine macrophages (ATCC)
were grown in RPMI supplemented with L-glutamine,
sodium pyruvate, and antibiotics.
2.5. Immunohistochemistry. Immunohistochemistry from
the carotid arteries was performed on formalin-ﬁxed,
paraﬃn-embedded tissue sections. 4μm slides were then
deparaﬃnated using xylol and ethanol.
Samples were incubated with the anti-CSE primary
monoclonal antibody (12217-1-AP Proteintech, Chicago,
IL, USA) at a dilution of 1 : 200. Other slides of the same
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samples were incubated with antihemoglobin (clone: goat
polyclonal HRP (ab19362), Proteintech Group, Rosemont,
IL 60018, USA) primary monoclonal antibody at a dilution
of 1 : 100; with HO-1 (clone: rabbit polyclonal (10701-1-
AP), Proteintech Group, Rosemont, IL 60018, USA) primary
monoclonal antibody at a dilution of 1 : 200; and with HO-2
(clone: rabbit polyclonal (14817-1-AP), Proteintech Group,
Rosemont, IL 60018, USA) primary monoclonal antibody
at a dilution of 1 : 400. Speciﬁc antibody binding was visual-
ized by the Dako EnVision FLEX/HRP and FLEX DAB3
Chromogen detection system (Dako, Glostrup, Danmark)
followed by hematoxylin counterstaining and coverage.
The intensity and distribution of protein immunostaining
were assessed by light microscopy (Leica DM2500 micro-
scope, DFC 420 camera and Leica Application Suite V3
software, Leica).
2.6. Dual Immunohistochemistry. Dual IHC was done as
follows. The CSE enzyme was speciﬁcally labeled with a
polyclonal antibody clone (12217-1-AP, Proteintech,
Manchester, UK; dilution 1 : 100) and detected by the
EnVision Flex HRP/DAB+ (brown color) procedure. This
was followed by a second incubation procedure with either
of the primary antibodies (CD4, CD34, or SMA) which
were detected by the Flex HRP system using the violet
VIP chromogen (Vector Laboratories, Burlingame, CA) as a
substrate. This setting clearly diﬀerentiated the DAB-
related brown staining and the VIP-related violet staining
even within the same cells by light microscopy. Methyl-
green solution (Vector Laboratories, Burlingame, CA)
was used to counterstain unlabeled cell nuclei of any of the
tissue constituents.
2.7. Hemoglobin Preparation. Hb of diﬀerent redox states,
that is, (Fe2+) oxyHb, (Fe3+) metHb, and ferrylHb, were pre-
pared as described [15]. Brieﬂy, Hb was isolated from fresh
blood drawn from healthy volunteers using ion-exchange
chromatography on a DEAE Sepharose CL-6B column.
MetHb was generated by incubation (30min, 25°C) of puri-
ﬁed Hb with a 1.5-fold molar excess of K3Fe(CN)6 over heme.
FerrylHb was obtained by incubation (1 h, 37°C) of Hb with a
10 : 1 ratio of H2O2 to heme. After oxidation, both metHb
and ferrylHb were dialyzed against saline (3 times for 3 hours
at 4°C) and concentrated using Amicon Ultra centrifugal ﬁl-
ter tubes (10,000 MWCO, Millipore Corp., Billerica, MA,
USA). Aliquots were snap-frozen in liquid nitrogen, and
stored at −80°C until use. The purity of each Hb preparation
was evaluated by SDS-PAGE followed by silver staining. The
purity of Hb preparations was above 99.9%. Hb concentra-
tions were calculated as described by Winterbourn [21].
2.8. Isolation and Oxidation of LDL. LDL was isolated from
the plasma of EDTA-anticoagulated venous blood of healthy
volunteers by gradient ultracentrifugation (Beckman Coulter
Inc., Brea, CA, USA). The density of plasma was adjusted to
1.3 g/mL with KBr and a two-layer gradient was made in a
Quick-Seal ultracentrifuge tube by layering saline on 10mL
plasma. Ultracentrifugation was performed at 302,000g for
2 hours at 4°C (VTi 50.2 rotor). LDL samples were kept at
−70°C until use, and the protein concentration was deter-
mined by Pierce BCA protein assay kit (Pierce Biotechnol-
ogy, Rockford, IL, USA). LDL oxidation was carried out at
37°C in a reaction mixture containing LDL (200μg/mL),
heme (5μmol/L), and H2O2 (75μmol/L).
2.9. Oxidation of LDL. LDL (200μg/mL) was oxidized with
heme (5μmol/L) and H2O2 (75μmol/L) in the presence or
absence of the sulﬁde donors NaSH, GYY4137, AP67, and
AP72 at concentrations of 20 and 200μmol/L at 37°C. Con-
jugated diene formation was monitored continuously for 1
hour at 234 nm. Delta OD234 nm was calculated by sub-
tracting optical density measured at the 0 time point from
optical density measured at 1 hour. The formations of lipid
hydroperoxides (LOOH) and thiobarbituric acid reactive
substances (TBARS) were measured at 60 minutes follow-
ing the initiation of lipid peroxidation. The method of Wolf
was used to evaluate LOOH content in the LDL samples
[14]. For the TBARS measurement, 50μL of a 200μg pro-
tein/mL LDL sample was mixed with 100μL of thiobarbitu-
ric acid reagent (0.375 g 2-thiobarbituric acid, 2.08mL HCl,
and 15mL 10% trichloroacetic acid to a ﬁnal volume of
100mL). After heating at 90°C for 20 minutes, the samples
were cooled and extracted with 200μL n-butanol. The upper
phase was measured spectrophotometrically at 532nm.
Results were calculated using a molar extinction coeﬃ-
cient of 1.56× 105M−1·cm−1 and are expressed as nmol
TBARs/mg protein.
2.10. Plaque Lipid Oxidation. Lipids were extracted from
human carotid artery plaques as described previously
[13]. Plaque lipids (0.5mg/mL) were incubated with Hb
(100μmol/L) in the presence or absence of the sulﬁde
donors NaSH, GYY4137, AP67, and AP72 at 200μmol/L
concentration for 4 days at 37°C. In other cases, complicated
lesions containing intraplaque hemorrhage were homoge-
nized in saline. These samples (0.5mg/mL) were incubated
at 37°C for 3 days in the presence or absence of the sulﬁde
donors NaSH, GYY4137, AP67, and AP72. Lipid peroxida-
tion was assessed by measuring LOOH and TBARs.
2.11. Hb Oxidation and Detection of Covalently Cross-Linked
Hb Species. Puriﬁed Hb (5μmol/L heme) was incubated with
H2O2 (25μmol/L) or oxidized LDL (50μg protein/mL) in the
presence or absence of the sulﬁde donors NaSH, GYY4137,
AP67, and AP72 at 37°C for 1 hour. For the detection of
the covalently cross-linked Hb species, 0.5μg of Hb sam-
ples were applied to 12.5% SDS-PAGE gels. After electro-
phoresis, proteins were transferred to a nitrocellulose
membrane (Amersham Biosciences Corp., Piscataway, NJ,
USA) and Hb was identiﬁed using an HRP-conjugated goat
anti-human Hb polyclonal antibody (ab19362-1 Abcam,
Cambridge, UK) at a dilution of 1 : 15,000.
2.12. Stopped-Flow Spectrophotometry. Kinetic measure-
ments were performed with a sequential stopped-ﬂow appa-
ratus (DX-18 MV, Applied Photophysics Ltd., Leatherhead,
UK) using a 150W Xe arc lamp. The reactions were followed
at λ=406, 425, 570, and 620nm. All kinetic traces were
collected in 20mmol/L phosphate buﬀer at pH7.40 at
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25°C. At least 3 kinetic runs were made and averaged at each
concentration to establish the corresponding kinetic traces.
2.13. Endothelial Cell Cytotoxicity Assay. LDL (200μg/mL)
was oxidized with heme (5μmol/L) and H2O2 (75μmol/L).
Oxidized LDL was incubated at 37°C overnight with the sul-
ﬁde donors NaSH, GYY4137, AP67, and AP72 at concentra-
tions of 20 and 200μmol/L. Conﬂuent HAoECs grown in 96-
well tissue culture plates were washed twice with PBS and
exposed to oxLDL samples for 6 hours. Cell viability was
assessed by MTT assay as described previously [22].
2.14. Endothelial Cell Monolayer Integrity Assay. Electric cell
substrate impedance sensing method was used to measure
endothelial monolayer integrity. HAoECs were cultured on
8-well electrode arrays (8W10E, Applied BioPhysics Inc.,
Troy, NY, USA). Upon conﬂuence, cells were challenged
with Hb (10μmol/L) oxidized with H2O2 (50μmol/L) in
the presence of sulﬁde donor molecules at the concentration
of 200μmol/L. The complex impedance spectrum was mon-
itored with an ECIS Zᴓinstrument (Applied BioPhysics Inc.,
Troy, NY, USA) for 3 hours in every minute. Intercellular gap
formation was calculated based on the diﬀerence between
monolayer resistance at 4000Hz at the 0 time point and 3
hours. In other experiments, HAoECs were treated with Hb
(20μmol/L) oxidized with plaque lipids (400μg/mL) in the
presence of sulﬁde donor molecules (200μmol/L) and
impedance spectrum was monitored for 12 hours. Intercellu-
lar gap formation was calculated based on the diﬀerence
between monolayer resistance at 4000Hz at the 0 time point
and 12 hours.
2.15. Western Blot. The cells were cultured in 6-well plates,
and upon reaching the conﬂuence, the cells were treated with
diﬀerent triggers. After 8 hours of treatment, the cells were
solubilized in protein lysis buﬀer containing 10mmol/L
Tris-HCl, 5mmol/L EDTA, 150mmol/L NaCl (pH7.2), 1%
Triton X-100, 0.5% Nonidet P-40, and protease inhibitors
(Complete Mini, F. Hoﬀmann-La Roche Ltd., Basel, Switzer-
land). In other experiments, tissue samples were homoge-
nized under liquid nitrogen and solubilized in protein lysis
buﬀer. Proteins (10–20μg) were applied to 12.5% SDS-
PAGE gels. After electrophoresis, proteins were transferred
to a nitrocellulose membrane (Amersham Biosciences Corp.,
Piscataway, NJ, USA). Proteins were identiﬁed using the
following antibodies: mouse anti-human HO-1 antibody
(Calbiochem, San Diego, CA, USA, 374087, dilution
1 : 2500), rabbit anti-human HO-2 antibody (Proteintech,
Chicago, IL, USA, 14817-1-AP), rabbit anti-human CSE
antibody (Proteintech, Chicago, IL, USA, 12217-1-AP,
dilution 1 : 1000), rabbit anti-human VCAM-1 (Santa Cruz
Biotechnology Inc., Dallas, TX, USA, sc8304, dilution
1 : 200), mouse anti-human GAPDH (Novus Biologicals,
Littleton, CO, USA NB-300-221, dilution 1 : 1000), anti-
rabbit IgG HRP-conjugate (GE Healthcare Life Sciences,
Piscataway, NJ, USA, NA934, dilution 1 : 15,000), and
anti-mouse IgG HRP-conjugate (GE Healthcare Life Sci-
ences, Piscataway, NJ, USA, NA931, dilution 1 : 15,000).
Antigen-antibody complex was detected by a horseradish
peroxidase chemiluminescence system according to the
manufacturer’s instructions (GE Healthcare Life Sciences,
Piscataway, NJ, USA). Quantiﬁcation was performed using
video densitometry (AlphaDigiDoc RT, Alpha Innotech
Corp., San Leandro, CA, USA).
2.16. Quantitative Real-Time PCR (qRT-PCR). ApoE−/−mice
were intraperitoneally injected with NaSH (56μmol/kg body
weight) or vehicle (PBS) in every other day over 8 weeks.
Parallel with the treatment, the mice were fed with athero-
genic diet. Control mice were fed with standard chow diet.
After, the mice were sacriﬁced and aortas were harvested.
Total RNA was isolated using RNAzol STAT-60 according
to the manufacturer’s instructions (cat. number Tl-4120,
TEL-TEST Inc., Friendswood, TX, USA). RNA concentra-
tion was measured with NanoDropTM 2000c spectropho-
tometer (cat. number S06497c, Thermo Scientiﬁc Inc.,
Waltham, MA, USA). After that, cDNA synthesis was per-
formed using a high-capacity cDNA kit (cat. number 43-
688-13, Applied Biosystems, Foster City, CA). We used
real-time PCR technique for quantiﬁcation of mRNA levels
of HO-1 (Mm00516005_m1, Thermo Fisher Scientiﬁc Inc.)
and beta-actin (Mm02619580_g1, Thermo Fisher Scientiﬁc
Inc.). TaqMan Universal PCR Master Mix was purchased
from Applied Biosystems (cat. number 4269510, Applied
Biosystems, Foster City, CA). Finally, we performed TaqMan
quantitative PCR (40 cycles at 95°C for 15 sec. and 60°C for
1min.) in 96-well plates with the Bio-Rad CFX96 (Bio-Rad
Laboratories Inc., Hercules, California, USA) detection sys-
tem. Results were expressed as mRNA expression normalized
to beta-actin.
2.17. Determination of Sulﬁde Level from Tissue with Zinc
Precipitation Assay. Sulﬁde levels were measured with zinc
precipitation method based on a method developed by
Gilboa-Garber [23] and modiﬁed by Ang et al. [24]. The
human carotid artery was homogenized under liquid nitro-
gen in 7.4 pH PBS and was sonicated. After that, the sample
was centrifuged at 12,000g for 15min and the lipid-free clear
supernatant was collected. 200μL sample was mixed with
350μL 1% zinc acetate and 50μL 1.5mol/L sodium hydrox-
ide and incubated for 60 minutes on a shaker. Incubation
step was followed by centrifugation at 2000g for 5 minutes
to pellet the generated zinc sulﬁde. The supernatant was then
removed, and the pellet washed with 1mL of distilled
water by vortexing extensively, followed by centrifugation
at 2000g for 5 minutes. The supernatant was then aspirated
oﬀ and the pellet reconstituted with 160μL of distilled water
and mixed with 40μL of premixed dye (20μL of 20mmol/L
dimethyl-p-phenylenediamine dihydrochloride (NNDP) in
7.2mol/L hydrochloric acid (HCl) and 20μL of 30mmol/L
iron(III) chloride (FeCl3) in 1.2mol/L HCl). After 10min,
the absorbance of the generated methylene blue (MB) was
measured with spectrophotometer at 667nm. Since during
the reaction 1mol/L MB formed from 1mol/L sulﬁde,
the concentration was determined by the MB’s extinction
coeﬃcient (30,200M−1·cm−1). Samples were normalized
for protein concentration.
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2.18. Experimental Units. “N” represents the number of tissue
samples used in each group. “n” denotes the number of rep-
lications of the independent results.
2.19. Study Approval. Collection of carotid artery plaques
from patients who underwent carotid endarterectomy
surgery was approved by the Scientiﬁc and Research
Ethics Committee of the Scientiﬁc Council of Health of the
Hungarian Government under the registration number of
DE OEC RKEB/IKEB 3712-2012.
2.20. Statistics. Data were analyzed by GraphPad Prism 5.02
software (GraphPad Software Inc., 7825 Fay Avenue, Suite
230 La Jolla, CA 92037). All statistics data are expressed as
mean± sem. Diﬀerences in means were analyzed by Student’s
t-test or one-way ANOVA with Dunnett’s post test as appro-
priate. p < 0 05 was considered signiﬁcant.
3. Results
3.1. CSE Is Upregulated in Human and Mouse Atheromatous
Plaques. To investigate whether CSE expression changes dur-
ing atherogenesis, we performed both immunostainings of
human carotid artery specimens and Western blotting.
Western blot analysis of human vessel samples revealed that
atheromatous lesions exhibit the higher content of CSE as
compared to the healthy artery, or complicated lesions
(Figure 1(a), lower panels). Localization of CSE by immuno-
staining (Figure 1(a), upper panels) demonstrated that CSE
was highly expressed in macrophages, and foam cells of ath-
eromatous plaque as well as in macrophages and foam cells of
complicated lesions showing visible evidence of intraplaque
hemorrhage (Figure 1(a), upper panel). For better visibility,
we present same histological pictures with higher magniﬁca-
tion as Supplementary Figure 1. We found that CSE-positive
cells were more common in the atheroma compared to the
complicated lesions. To evaluate CSE expression more accu-
rately in diﬀerent cell types of human samples, we performed
double staining with cellular markers for macrophages,
endothelial cells, and smooth muscle cells (Figure 2). Double
immunohistochemistry revealed tissue macrophages (violet)
presenting CSE expression (brown color) in complicated
lesions (upper panels). Endothelium (middle panels, violet)
was also stained for CSE (middle panels, brown color).
Importantly, we identiﬁed myoﬁbroblasts in complicated
lesions expressing high CSE level (Figure 3). SMA-positive
myoﬁbroblasts (violet) coexpressing CSE (brown color) in
their cytoplasm were abundant.
To further support this observation, we compared CSE
expression in the aorta of ApoE−/− mice fed with normal
or atherogenic diet for 8 weeks. Mice fed on the athero-
genic diet provoked extensive atherosclerotic plaque for-
mation which was associated with elevated expression of
CSE as demonstrated by Western blot (Figure 1(b), lower
panels). CSE was localized in endothelium, macrophages,
and foam cells as revealed by immunohistochemistry
(Figure 1(b), upper panel). For improved visibility, we show
the same histological pictures with higher magniﬁcation as
Supplementary Figure 2.
Furthermore, we investigated the endogenous sulﬁde
levels in diﬀerent types of the carotid arteries and found
increased sulﬁde levels in atheroma compared to healthy
vessel and complicated lesion (Figure 1(c)).
3.2. Sulﬁde Inhibited Lipid Peroxidation In Vitro and In Vivo.
In accordance with previous ﬁndings [17], we observed that
administration of NaSH solution reduced, whereas inhibition
of CSE activity by DL-propargylglycine (PPG) increased ath-
erogenic diet-induced atherosclerotic plaque formation in
ApoE−/− mice (Figure 4(a), left and right panels). Therefore,
we examined the extent of oxidative injury by performing
immunoﬂuorescence staining for the cytotoxic lipid peroxi-
dation product 4-hydroxynonenal (4-HNE) in aortic root
in a vehicle or NaSH-treated ApoE−/− mice. Strong positive
4-HNE immunostaining was observed in aorta from
vehicle-treated mice, whereas 4-HNE level was markedly
lower in aorta from NaSH-treated mice (Figure 4(b), left
panel). To further conﬁrm that lipid peroxidation was inhib-
ited by sulﬁde, we measured thiobarbituric acid reactive sub-
stance (TBARS) content of the aorta derived from a vehicle
or NaSH-treated ApoE−/− mice. TBARS content of sulﬁde-
treated aorta was approximately one-third of the vehicle-
treated control samples (Figure 4(b), right panel). Since heme
oxygenase-1 (CSE) was shown to be induced by lipid hydro-
peroxide [25], we also tested whether sulﬁde alters HO-1
expression in an atherosclerotic mouse model. HO-1 was
strongly upregulated in the aorta of ApoE−/− mice fed with
atherogenic diet and it was mainly expressed by endothelial
cell and macrophages (Figure 4(c)). We found that HO-1
mRNA level was reduced in NaSH-treated mice, presumably
due to the attenuated oxidative stress (Figure 4(d)). Next,
we examined whether sulﬁde releasing molecules could
prevent lipid peroxidation of lipids derived from human
atheromatous lesions in vitro. We provoked lipid peroxida-
tion in vitro with heme or hemoglobin (Hb) to model intra-
plaque hemorrhage. Heme induced a robust increase in
lipid peroxides (LOOH) and TBARS content of plaque lipids
which was inhibited by all sulﬁde donors (Suppl. Figures 3A
and 3B). Similarly, sulﬁde-releasing molecules attenuated
Hb-mediated formation of both LOOH and TBARS (Suppl.
Figures 3C and 3D). We also checked whether polysulﬁdes
and decomposed sulﬁde donors alter lipid peroxidation
in vitro. Neither polysulﬁde nor decomposed sulﬁde donors
were able to block lipid peroxidation (Suppl. Figure 5).
3.3. Sulﬁde Inhibited the Formation of Lipid-Peroxidation
Products in Human Hemorrhaged Lesions. Next, we exam-
ined whether the diﬀerent H2S-releasing compounds could
prevent hemorrhage-mediated lipid-peroxidation upon
intraplaque hemorrhage. Human carotid endarterectomy
specimens with obvious macroscopic evidence of intraplaque
hemorrhage (Suppl. Figure 4A) were homogenized and incu-
bated at 37°C in the presence or absence of the sulﬁde donors
(200μmol/L). We determined LOOH and TBARS content
of the samples at day 0 and day 4. During the four-day
incubation, LOOH content increased about 2.7-fold,
whereas the level of TBARS elevated by 2.4-fold (Suppl.
Figures 4B and 4C). The formation of both LOOH and
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TBARS were attenuated by the sulﬁde donors (Suppl.
Figures 4B and 4C). Moreover, AP67 and AP72 were able
to decrease LOOH content below the basal LOOH level
measured at day 0 (Suppl. Figure 4B).
3.4. Sulﬁde Donor Molecules Inhibit Oxidative Cross-Linking
of Hb Subunits. Covalent cross-linking of Hb occurs in
advanced atherosclerotic lesions. To model the oxidative
environment present in the atherosclerotic plaque in vitro,
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Figure 1: CSE is markedly upregulated in atheromatous lesions. (a, upper panels) Immunohistochemistry detection of the CSE expression in
human carotid artery specimens. Macroscopic pictures, H&E, and CSE staining are shown. Magniﬁcation of the human histology samples was
150x. Arrows indicate endothelial cells, crosses show smooth muscle cells, and comparison signs mark macrophages. (a, lower panels) Pieces
of carotid artery representing the healthy vessel; atheromatous and complicated lesions were selected by macroscopic examination.
Representative Western blot showing CSE expression in carotid artery tissue lysates (20 μg/lane) (N = 3, three human carotid artery
specimens from three patients in each group). Immunoblots were reprobed with GAPDH. The bar graph shows CSE expression
normalized to GAPDH. ∗∗∗p < 0 005 and ∗p < 0 05 compared to healthy samples. (b) ApoE−/− mice were kept on normal chow diet or
atherogenic diet for 8 weeks. (b, upper panels) H&E and CSE staining are shown. Magniﬁcation of the mice aortas was 700x. Arrows
indicate endothelial cells, crosses show smooth muscle cells, and comparison signs mark macrophages. (b, lower panels) Representative
Western blot showing CSE expressions of carotid artery samples (10 μg/lane) (n = 3, each performed in triplicate). Immunoblots were
reprobed with GAPDH. The bar graph shows CSE expression normalized to GAPDH. (c) Endogenous H2S levels in diﬀerent types of the
carotid arteries (N = 6).
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we used H2O2 (25μmol/L) or oxLDL (50μg/mL) to trigger
such oxidative cross-linking of Hb (5μmol/L) in the presence
or absence of sulﬁde donors. Covalently cross-linked Hb spe-
cies were subsequently detected by Western blot analysis.
The formations of dimeric, tetrameric, and multimeric
Hb species were detected in both H2O2 and oxLDL-
treated Hb samples. At a concentration of 200μmol/L,
all the sulﬁde-generating molecules signiﬁcantly inhibited
the formation of covalently cross-linked Hb multimers
triggered by either H2O2 or oxLDL (Figures 5(a)–5(d)).
AP67 and AP72 provided complete inhibition against
H2O2-induced Hb oxidation, and these donors were also
the most eﬀective at inhibiting oxLDL-mediated Hb oxida-
tion (Figures 5(a)–5(d)).
3.5. Reactions of FerrylHb with Sulﬁde. To test the possibility
that the observed protective eﬀects of sulﬁde donors were due
to the reduction of ferrylHb, we next investigated the kinetics
of the reaction of ferrylHb species with sulﬁde in a cell-
free system using stopped-ﬂow spectrophotometry. Ini-
tially, ferrylHb was prepared in situ by the reaction of
metHb with 5 molar equivalents of H2O2 in the ﬁrst mix-
ing cycle of a sequential stopped-ﬂow experiment. Under
our experimental conditions, the formation of ferrylHb
was complete in 400 s and resulted in spectral transitions
(see the 350–500 and 500–650nm ranges on Figure 5(a), left
and right panels) that were characteristic to the formation of
ferrylHb. Therefore, sulﬁde was reacted with ferrylHb in the
second mixing cycle using a delay time of 400 s. Rapid
changes in the UV-vis spectra predicted a favorable reaction
between sulﬁde and ferrylHb under these conditions. The
appearance of a new peak at 620nm together with the shift
of the Soret band at 400nm and the absorbance increases at
530 and 580nm were indicative of the formation of sulfhe-
moglobin (Figure 6(a), left and right panels). Kinetic traces
were measured at a >10-fold excess of sulﬁde over ferrylHb
to maintain pseudo-ﬁrst-order conditions and recorded ini-
tially at 406, 425, and 570nm (Figure 6(b), left and right
panels). Under these conditions, they exhibited a biexponen-
tial character, which most likely corresponded to separated
reactions of the alpha and beta chain ferryl heme centers (fas-
ter and slower phase, resp.) as shown before. The obtained
pseudo-ﬁrst-order rate constants from the double exponen-
tial ﬁts of the kinetic traces at 406, 425, and 570 nm show
similar linear correlations with the applied sulﬁde concentra-
tions, indicating ﬁrst-order dependencies of the rate law on
both ferrylHb and sulﬁde concentrations (Figure 6(b), right
panel). Therefore, the apparent second-order rate constants
at pH7.4 were calculated from the slopes of the lines on
Figure 6(b), right panel, to be (1.43± 0.06)× 103M−1·s−1
and (6.5± 0.2)× 102M−1·s−1 for the alpha and beta chains,
respectively. The previous report proposed that related fer-
rylHb species are generated in the reactions of oxyHb with
H2O2 as with metHb [26]. Indeed, we observed similar kinet-
ics with sulﬁde for the ferrylHb species that were produced in
the reaction of oxyHb with H2O2 as the ones described above
for metHb (data not shown).
However, kinetic traces that were recorded at 620nm
(representing the formation of sulfheme Hb) (Figure 6(c),
left panel) indicated two orders of magnitude faster rates
(also exhibiting double-exponential behaviors with second-
order rate constants of (1.7± 0.1)× 105 and (6.5± 0.3)×
104M−1·s−1) (Figure 6(c), right panel). We obtained prelimi-
nary kinetic evidence that the relatively slow reactions
recorded at 425nm and the 2 orders of magnitude faster
reactions at 620 nm were parallel and not consecutive reac-
tions. As mentioned above, ferrylHb represents a mixture
of oxidized Hb species, where an unpaired electron is located
at diﬀerent sites of the protein [27]. Therefore, we propose
that the observed kinetically isolated reactions were due to
diﬀerent ferrylHb species reacting with sulﬁde. We are cur-
rently investigating the chemical nature of these ferrylHb
species, but their characterization is outside the scope of the
present study.
3.6. Hb-Lipid Interactions and Subsequent Endothelial
Responses Are Attenuated by Sulﬁde. Interactions between
Hb and lipids upon intraplaque hemorrhage result in the
formation of reactive lipid mediators as well as oxidized Hb
species. These molecules trigger oxidative stress and cell acti-
vation, respectively. To investigate whether sulﬁde could
attenuate these harmful reactions, we treated oxidized LDL
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Figure 2: Double immunohistochemistry is demonstrating CSE
expression in diﬀerent cellular compartments of early (left)
and complicated (right) atherosclerotic plaques of the carotid
artery. Upper panels: CSE (DAB, brown color) and CD4 (VIP,
violet) highlighting tissue macrophages (arrows); middle panels:
CSE (DAB, brown color) and CD34 (VIP, violet) presenting
endothelial cells (arrows); and lower panels: CSE (DAB, brown
color) and smooth-muscle actin (VIP, violet) referring to
smooth-muscle cells (arrows) and myoﬁbroblasts (asterisk)
(×400 magniﬁcation).
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with sulﬁde donors for 4 hours. Then, HAoECs were exposed
to the LDL samples for 6 hours. Oxidized LDL decreased cell
viability by about 97% (Figure 7(a)). Pretreatment of oxLDL
with sulﬁde donors at the concentration of 200μmol/L
signiﬁcantly attenuated oxLDL induced to HAoECs
(Figure 7(a)). AP67 and AP72 were more potent at inhibiting
LDL-induced cytotoxicity presumably because they generate
H2S more eﬃciently than GYY4137 [19] (Figure 7(a)). Suble-
thal concentrations of oxLDL induced the expression of
heme oxygenase-1 (HO-1), a stress-responsive protein in
HAoECs (Figure 7(b)). We found that HO-1 expression
provoked by a sublethal dose of oxLDL was suppressed
by AP67 and AP72 but not by NaSH and GYY4137 in
HAoECs (Figure 7(b)). We also tested the constitutive
heme oxygenase-2 (HO-2) expression in these samples
and we found that HO-2 level remained unchanged
(Figure 7(b)). H2S donors at concentrations we used did
not enhance the level of HO-1 and HO-2 in HAoECs (data
not shown). Thus, in our system, heme oxygenases were
not involved in the cellular responses provided by H2S. Oxi-
dized Hb species in particular ferrylHb trigger endothelial
cell activation, characterized by elevated expression of adhe-
sion molecules and increased intercellular permeability.
Therefore, we next examined whether sulﬁde donor mole-
cules could modulate endothelial responses via inhibiting fer-
rylHb formation. Hb was treated with H2O2 in the absence or
presence of the sulﬁde releasing molecules. Conﬂuent
HAoECs were then treated with the obtained samples, and
VCAM-1 expression as a marker of endothelial cell activa-
tion, endothelial monolayer resistance, and intercellular gap
formation was investigated.
We found that Hb samples treated with H2O2 in the pres-
ence of slow sulﬁde-releasing molecules were able to attenu-
ate VCAM-1 expression, while NaSH could not diminish it
(Figure 7(c)). Then, we investigated the integrity of HAoECs
monolayers. Native Hb did not change HAoECs monolayer
resistance compared to control cells during the 3-hour treat-
ment (Figure 7(d), lower panel), but when HAoECs mono-
layers were exposed to oxidized Hb, monolayer resistance
was signiﬁcantly decreased (Figure 7(d), lower panel), sug-
gesting that oxidized Hb provoked intercellular gap forma-
tion in accordance with previous observations [11, 15].
Importantly, each sulﬁde-releasing molecule attenuated the
decline of monolayer resistance (Figure 7(d), lower panel)
presumably via the inhibition of ferrylHb formation.
Moreover, AP67 and AP72 not only inhibited the oxHb-
mediated decrease in monolayer resistance but also
increased resistance signiﬁcantly above the nontreated
HAoECs monolayer’s resistance (Figure 7(d), lower panel).
To conﬁrm that the observed decrease in monolayer resis-
tance upon treatment of HAoECs with oxidized Hb was
due to intercellular gap formation, we performed immuno-
staining on cells after oxidized Hb exposure (Figure 7(d),
upper panel). Accordingly, in the present studies, endothe-
lium exposed to oxHb exhibited gaps between the cells visu-
alized by F-actin staining (Figure 7(d), upper panel). As
demonstrated in panel E, rearrangement of F-actin cytoskel-
eton and subsequently the formation of intercellular gaps
were prevented by NaSH, GYY4137, and AP67. We also
tested if polysulﬁdes and decomposed sulﬁde donors could
aﬀect endothelial responses. Interestingly, we found that
polysulﬁdes, but not decomposed sulﬁde donors, were able
to inhibit oxLDL-induced cell death (Suppl. Figures 6A and
6B). Furthermore, increased expression of HO-1 and
VCAM-1 provoked by oxLDL or oxHb at a sublethal dose
was not altered by polysulﬁdes and decomposed sulﬁde
donors (Suppl. Figures 6C and 6D).
3.7. Atherogenic Lipids and Proinﬂammatory Cytokines
Increased the Expression of CSE in Diverse Cells of the
Atherosclerotic Vessel Wall. To identify triggers and cell types
responsible for altered CSE expression in the atherosclerotic
vessel wall, we next exposed HASMCs, macrophages, and
HAoECs to diﬀerent agonists considered relevant in athero-
genesis. First, we examined the eﬀect of lipids, for example,
LDL and plaque lipids extracted from human aorta speci-
mens with lipid-rich atheromatous plaques. We challenged
the cells with native and oxidized forms of these lipids and
Complicated sclerotic plaque
20 휇m
(a)
Myofibroblast
20 휇m
(b)
Figure 3: CSE expression in activated myoﬁbroblasts in a cellular area of a complicated sclerotic plaque. (a) SMA+ myoﬁbroblasts (VIP,
violet) partially coexpress CSE (DAB, brown staining) in their cytoplasm. Additional CSE labeling can be observed in tissue macrophages
(brown only) (×400 magniﬁcation). (b) A single enlarged SMA+ ﬁbroblast-type cell with cytoplasmic brown CSE-related colabeling
(×1000 magniﬁcation).
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applied H2O2 as a positive control (Figure 8(a)). We found
that all the three cell types expressed CSE and that H2O2
exposure upregulated the expression of this H2S synthesizing
enzyme in HASMCs and macrophages. Both HASMCs and
macrophages responded to oxLDL, native, and oxidized pla-
que lipids by upregulating the expression of CSE (Figure 8(a),
left and middle panels). Next, we challenged the cells with
diﬀerent forms of Hb and Hb breakdown products such as
heme and iron which are known to accumulate in the athero-
sclerotic lesions upon intraplaque hemorrhage [10]. When
exposed to Hb, oxidized Hb, or heme, HASMCs and macro-
phages upregulated the expression of CSE, whereas iron
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Figure 4: Sulﬁde inhibits lipid-peroxidation in vivo and in vitro. (a, left panel) Representative oil red O staining of aorta derived fromApoE−/−
mice fed with atherogenic diet and treated with NaSH (N = 9), PPG (N = 5), or vehicle (PBS, N = 21) for 8 weeks. (a, right panel)
Quantiﬁcation of atherosclerotic plaque size was performed with ImageJ software. (b, left panel) Representative aortic sections (6 μm)
stained for F-actin (phalloidin-FITC, green), 4-HNE (red), and DNA (Hoechst, blue) (N = 9). (b, right panel) TBARS content of aorta
derived from ApoE−/− mice fed with atherogenic diet and treated with vehicle (N = 9) or NaSH for 8 weeks (N = 9). (c) ApoE−/− mice
were fed with regular diet (N = 9) or atherogenic diet for 8 weeks. Parallel with the atherogenic diet, the mice were kept intraperitoneally
vehicle (N = 9) or NaSH (N = 9). Immunohistology was showing hematoxylin and eosin and HO-1 staining of mice aorta samples.
Endothelial cells are indicated by arrows, smooth muscle cells were marked by cross, and macrophages were marked by comparison signs.
The magniﬁcation of the mice aortas was 700x. (d) Real-time qPCR was showing HO-1 relative expression in mouse aorta. ∗ indicates
statistical signiﬁcance (p < 0 05). ∗∗∗ indicates statistical signiﬁcance (p < 0 0001).
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treatment caused a marked decrease of CSE expression in
HASMCs, but did not modulate CSE expression in macro-
phages (Figure 8(b), left andmiddlepanels).Wealsoexamined
the upregulation of CSE by various forms of hemoglobin,
lipids, and proinﬂammatory cytokines in HAoECs. CSE
expression was not altered in HAoECs exposed to oxHb,
oxLDL, and oxidized lipids derived from atheromatous pla-
que (Figures 8(a) and 8(b), right panels). To examine the
eﬀect of proinﬂammatory mediators, we next exposed the
cells to IL-1β and TNF-α. Figures 8(c) shows that CSE
expression was induced in HASMCs and macrophages after
cytokine stimulation. On the contrary, CSE level was signif-
icantly increased in cells treated with TNF-α as it was
observed in HAoECs (Figure 8(c), right panels).
4. Discussion
The oxidative environment in the atherosclerotic lesion
triggers lysis of invading erythrocytes and the subsequent
release of Hb upon intraplaque hemorrhage [10]. A com-
plex interplay exists between atheroma lipids and cell-
free Hb that leads to further lipid-peroxidation and Hb
oxidation [10–12, 22].
In the reactions between Hb and plaque lipids, diﬀerent
oxidized Hb derivatives are formed (metHb (Fe3+), ferrylHb
(Fe4+=O2−)) [10–12], resulting in the covalently cross-
linked species. In our current study, we demonstrated that
sulﬁde inhibited oxidative cross-linking of Hb subunits, the
hallmark of the ferrylHb formation. These eﬀects could be
attributed to the ability of sulﬁde to reduce LOOH content
of oxLDL because LOOH was identiﬁed previously as the
most cytotoxic lipid-peroxidation product in oxLDL toward
vascular endothelium [22]. However, as we argued previ-
ously, the antioxidant properties of sulﬁde in biological
systems are most likely not due to direct scavenging of oxi-
dant species, because protein thiols and GSH are present in
much larger concentrations compared to sulﬁde. Hb cross-
linking proceeds via ferrylHb intermediate species, those we
found to be scavenged rapidly by sulﬁde, hence providing
an alternative molecular model for sulﬁde-mediated inhibi-
tion of Hb oligomerization. The measured rate constants
for the reactions of ferrylHb species with sulﬁde represent
at least 1–3 orders of magnitude faster reactions (for the
slower reactions recorded at 425nm and the faster ones
at 620nm, resp.) compared to those with ascorbate or
urate [28] that are the previously proposed primary heme-
redox-intermediate-scavenging antioxidants (because thiols
in most cases have no access to the metal center at the active
site). Also, the relatively high stability of the ferrylHb species
implies that Hb oligomers must form in much slower reac-
tions. Furthermore, the fact that Hb oligomerization was
associated with intraplaque hemorrhage suggests a role
for ferrylHb-initiated oxidative stress in the underlying
molecular mechanisms of the pathophysiology of compli-
cated atherosclerotic lesions [10]. Hence, the demonstration
of sulﬁde-mediated reduction of ferrylHb species is a novel
observation which could explain at least some of the observed
cytoprotective eﬀects of sulﬁde in our current model and
adds to the rapidly growing body of literature detailing
H2S-mediated cytoprotection.
Additionally, oxidized Hb species, in particular ferrylHb,
induce proinﬂammatory signaling targeted to the vascular
endothelium. By inhibiting Hb oxidation, sulﬁde donors also
attenuated Hb oxidation-associated decrease in endothelial
monolayer integrity and intercellular gap formation, as well
as the induction of the adhesion molecule, VCAM-1.
Oxidized Hb species release heme, a potent trigger of
lipid peroxidation [14, 25]. In our current study, sulﬁde
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Figure 5: Sulﬁde inhibits the formation of covalently cross-linked Hb multimers. (a) Hb (5 μmol/L) was incubated with H2O2 (75 μmol/L) in
the presence or absence of the H2S donors NaSH, GYY4137, AP67, and AP72 (200 μmol/L) at 37
°C for 90 minutes. Samples (0.5 μg Hb) were
subjected to SDS-PAGE and Hb species were detected by Western blotting. Representative experiment, n = 3. (b and d) Quantiﬁcation of the
multimer formation was showed. (c) Hb (5 μmol/L) was incubated with oxLDL (50 μg/ml) in the presence or absence of the sulﬁde donors
NaSH, GYY4137, AP67, and AP72 (200 μmol/L) at 37°C for 4 hours. Samples (0.5μg Hb) were subjected to SDS-PAGE and Hb species
were detected by Western blotting. Representative experiment, n = 3. ∗∗∗ indicates statistical signiﬁcance (p < 0 0001).
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Figure 6: Reactions of ferrylHb with sulﬁde. (a, left and right panels) Representative UV-vis spectra of 4 μmol/L metHb (black line), reaction
of 4 μmol/L metHb with 8μmol/L H2O2 after 400 s (red line) and reaction of 4μmol/L ferrylHb with 100μmol/L sulﬁde after an additional
60 s (blue line). Arrows indicate wavelength values where the kinetic runs were recorded. (b, left panel) Representative stopped-ﬂow kinetics
traces for the reaction of 4μmol/L ferrylHb with 100 μmol/L sulﬁde at 406 nm (circles) and 425 nm (squares) and the corresponding double
exponential ﬁts (solid lines). (b, right panel) Sulﬁde concentration dependencies of the obtained pseudo-ﬁrst-order rate constants from the
double exponential ﬁts of the stopped-ﬂow kinetic traces (λ= 425 nm). MetHb (4 μmol/L) was reacted with H2O2 (8 or 20 μmol/L) in the
presence of sulﬁde (100–700 μmol/L). The faster (circles) and slower (squares) reactions represent reactions of the ferryl moieties of the
alpha and beta chains, respectively. Data points and error bars represent the average and standard deviations of 4 independent
experiments. (c, left panel) Representative stopped-ﬂow kinetics traces for the reaction of 4 μmol/L ferrylHb with 100 μmol/L sulﬁde at
620 nm (blank circles) and the corresponding double exponential ﬁt (solid lines). (c, right panel) Sulﬁde concentration dependence of the
pseudo-ﬁrst-order rate constant for the reaction of ferrylHb with sulﬁde from the double exponential ﬁts of the kinetic traces, where
ferrylHb was generated in the reaction of 8μmol/L metHb with 40μmol/L H2O2 in the ﬁrst mixing cycle of a sequential stopped-ﬂow
experiment, followed by mixing with sulﬁde solutions in a 1 : 1 ratio in the second mixing cycle after a 240 s delay time. The faster (circles)
and slower (squares) reactions represent the reactions of the ferryl moieties of the alpha and the beta chains, respectively. Data points and
error bars represent the average and standard deviations of 3 independent experiments.
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Figure 7: Endothelial responses provoked by Hb-lipid interactions are attenuated by sulﬁde donors. (a) OxLDL (200 μg/mL) was incubated
with sulﬁde donors NaSH, GYY4137, AP67, and AP72 at the concentrations of 20 and 200 μmol/L at 37°C for 24 hours. Conﬂuence HAoECs
were exposed to the LDL samples for 4 hours then cell viability was determined by MTT assay. Representative experiment, n = 3, each
performed in 8 wells in parallel. (b) OxLDL (200 μg/mL) was incubated with sulﬁde donors NaSH, GYY4137, AP67, and AP72 at the
concentration of 20 and 200μmol/L at 37°C for 24 hours. Conﬂuence HAoECs were exposed to LDL samples (50 μg/mL) for 8 hours.
HO-1 and HO-2 protein expressions were determined by Western blotting. Representative experiment, n = 3. (c–e) Hb (10 μmol/L) was
incubated with H2O2 (50 μmol/L) in the presence or absence of sulﬁde donors NaSH, GYY4137, AP67, and AP72 (200 μmol/L) at 37
°C
for 90 minutes. (c) Conﬂuence HAoECs were exposed to the obtained Hb samples for 8 hours and VCAM-1 expression was determined
by Western blotting. Representative experiment, n = 3. (d, lower panel) Conﬂuence HAoECs cultured in ECIS plates were exposed to the
obtained Hb samples and transendothelial electrical resistance was monitored by ECIS instrument for 3 hours. Representative experiment,
n = 3, each performed in triplicate (d, upper panel). HAoECs grown on coverslips, upon reaching conﬂuence cells were exposed to the Hb
samples for 8 hours. Cells were stained for F-actin (phalloidin-TRITC, red) and DNA (Hoechst, blue). White arrows show intercellular
gaps. Representative image, n = 5. ∗∗ indicates statistical signiﬁcance (p < 0 001). ∗∗∗ indicates statistical signiﬁcance (p < 0 0001).
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donors inhibited Hb or heme-mediated oxidation of soft
plaque lipids derived from human atheroma. We have also
shown that sulﬁde-releasing molecules attenuated lipid per-
oxidation in complicated lesions exhibiting evidence of hem-
orrhage. Chemically, H2S is a reductant, and the previous
study revealed that it converts lipid hydroperoxides into
lipid-alcohols in oxLDL in vitro [29]. Importantly, we found
that sulﬁde reduced lipid hydroperoxide content of compli-
cated lesions with hemorrhage.
Using human carotid artery specimens and mice aorta
derived from an experimental atherosclerosis model, here,
we demonstrated that the expression of CSE is markedly
upregulated in vessels with atheromatous plaques and com-
plicated lesions. Macrophages, activated myoﬁbroblasts,
and foam cells exhibited marked CSE expression in the
lesions, and interestingly, the CSE-positive cells were more
common in atheromatous plaques compared to complicated
lesions. The atherosclerotic plaque is rich in reactive oxygen
species, reactive lipid mediators, proinﬂammatory cytokines,
and upon plaque hemorrhage, contains diﬀerent hemoglobin
oxidation products. Here, we showed that all the major cell
types of the atherosclerotic vessel wall, that is, endothelial
cells, vascular smooth muscle cells, and macrophages,
expressed CSE in a stress-responsive manner. We identiﬁed
proinﬂammatory cytokines (TNF-α, IL-1β), lipid mediators
(oxLDL, plaque lipid), and hemoglobin oxidation products
(ferrylHb) that could contribute the high expression of CSE
in blood vessels obtained from human atheromatous plaques
and complicated lesions.
As we investigated the eﬀects of a CSE inhibitor (PPG) in
atherosclerotic plaque formation in vivo, we found that PPG
treatment increased plaque formation in the presence of an
atherogenic diet conﬁrming Wang et al.’s and Mani et al.’s
previous ﬁndings [17, 18]. This suggests that the CSE/H2S
system inhibits the development of atheromatous lesions.
Unfortunately, in ApoE−/− mice model, there is no evidence
of the development of complicated lesions. To our knowl-
edge, there is no animal model for studying the fate of
complicated lesions. In human, the main pathogenic event
in the progression of atherosclerosis is the formation of
complicated lesions with obvious macroscopic evidence of
intraplaque hemorrhage. We demonstrate that complicated
lesions with obvious macroscopic evidence of intraplaque
hemorrhage in humans exhibit less CSE expression com-
pared to an atheromatous plaque. These data support the
beneﬁcial role of CSE/H2S in the progression of atherosclero-
sis and does not provide evidence for an association of
CSE upregulation and atherosclerosis. It should be noted
that there is no animal model available at the moment
for verifying the function of H2S for controlling the proox-
idant and proinﬂammatory ferrylHb. Our aim is in the
future to establish a model for the development and pro-
gression of complicated lesions. Prevention of plaque rup-
ture and inﬁltration of red blood cells into the atheroma
might provide a novel approach to inhibit the progression
of lesions in human.
In conclusion, the present study provides evidence that
high vascular expression of CSE deﬁnes atheromatous
plaques and complicated lesions, both in human carotid ath-
erosclerotic lesions and in an experimental hyperlipidemia-
induced atherosclerotic mouse model. Based on our in vitro
ﬁndings, we propose that the elevated CSE expression might
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Figure 8: Modulators of CSE expression in HASMCs, macrophages, and endothelial cells. (a) Conﬂuent HASMCs, RAW264.7 cells,
and HAoECs were exposed to LDL (50 μg/mL), oxLDL (50 μg/mL), PL (500 μg/mL), oxPL (500 μg/mL), and H2O2 (100 μmol/L) for
8 hours. (b) Conﬂuent HASMCs, RAW264.7 cells, and HAoECs were exposed to Hb, oxHb, heme (50 μmol/L heme group each),
and Fe-ammonium citrate (50 μmol/L) for 8 hours. (c) Conﬂuent HASMCs, RAW264.7 cells, and HAoECs were exposed to IL-1β
(1–5-10 ng/mL) or TNF-α (1–5-10 ng/mL) for 8 hours. Representative Western blots showing CSE expressions of cell lysates (20 μg/lane)
(n = 3). Immunoblots were reprobed with GAPDH.
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serve as a compensatory atheroprotective response, in which
the produced H2S prevents the formation of prooxidant and
proinﬂammatory lipid mediators and Hb forms and subse-
quent endothelial responses provoked by these species
(Figures 9(a) and 9(b)).
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Supplementary Materials
Supplementary Figure 1: CSE is markedly upregulated in
human atheromatous lesions immunohistochemistry detec-
tion of the CSE expression in human carotid artery speci-
mens. H&E and CSE staining are shown. Magniﬁcation of
the human histology samples was 150x. Arrows indicate
endothelial cells, crosses show smooth muscle cells, and com-
parison signs mark macrophages. Supplementary Figure 2:
CSE is markedly upregulated in mouse atheromatous lesions.
ApoE−/−mice were kept on normal chow diet or atherogenic
diet for 8 weeks. H&E and CSE staining are shown. Magniﬁ-
cation of the mice aortas was 700x. Arrows indicate endothe-
lial cells, crosses show smooth muscle cells, and comparison
signs mark macrophages. Supplementary Figure 3: sulﬁde
donors were inhibited lipid peroxidation in vitro. (A-B) Soft
plaque lipids (400μg/mL) were incubated with heme
(5μmol/L) alone or in the presence of sulﬁde donors NaSH,
GYY4137, AP67, and AP72 (200μmol/L) at 37°C for 24
hours, followed by determination of TBARS and LOOH.
Representative experiment, N = 3, each performed in tripli-
cate. (C-D) Soft plaque lipids (400μg/mL) were incubated
with Hb (20μmol/L) alone or in the presence of sulﬁde
donors NaSH, GYY4137, AP67, and AP72 (200μmol/L) at
37°C for 48 hours, followed by determination of TBARS
and LOOH. Representative experiment, n = 3, each per-
formed in triplicate. Supplementary Figure 4: sulﬁde inhibits
lipid-peroxidation in complicated lesions. (A) Macroscopic
picture, H&E staining, and Hb staining of human compli-
cated lesions are shown. (B-C) Human carotid artery speci-
mens with obvious macroscopic evidence of intraplaque
hemorrhage were homogenized. The homogenate (5mg/
mL) was incubated in the presence or absence of the sulﬁde
donors NaSH, GYY4137, AP67, and AP72 (200μmol/L) at
37°C for 4 days. LOOH and TBARS levels were determined
on day 0 and day 4. Representative experiment, n = 3.
Supplementary Figure 5: polysulﬁdes and decomposed
sulﬁde donors not able to block the lipid peroxidation.
(A) LDL (200μg/ml) was incubated with heme (5μmol/L)
and H2O2 in the presence or absence of HSX
− or decomposed
sulﬁde donors NaSH, GYY4137, AP67, and AP72 at the con-
centrations of 20 and 200μmol/L at 37°C for 60 minutes
followed by determination of TBARS and LOOH. Represen-
tative experiment, n = 3, each performed in triplicate. (B)
Soft plaque lipids (400μg/mL) were incubated with heme
(5μmol/L) alone or in the presence of HSX− or decom-
posed sulﬁde donors NaSH, GYY4137, AP67, and AP72
(200μmol/L) at 37°C for 16 hours, followed by determination
of TBARS and LOOH. Representative experiment, n = 3,
each performed in triplicate. (C) Soft plaque lipids (400μg/
mL) were incubated with Hb (20μmol/L) alone or in the
presence of HSX− or decomposed sulﬁde donors NaSH,
GYY4137, AP67, and AP72 (200μmol/L) at 37°C for 16
hours, followed by determination of TBARS and LOOH.
Representative experiment, n = 3, each performed in tripli-
cate. Supplementary Figure 6: polysulﬁdes and decomposed
sulﬁde donors do not prevent Hb-lipid interactions on endo-
thelial cells. (A-B) OxLDL (200μg/mL) was incubated with
HSX− or decomposed sulﬁde donors NaSH, GYY4137,
AP67, and AP72 at the concentration of 200μmol/L at 37°C
for 16 hours. HUVECs were treated with the samples for
6 hours then cell viability was determined by MTT assay.
Representative experiment, n = 3, each performed in 8
wells in parallel. OxLDL (200μg/mL) was incubated with
HSX− or decomposed sulﬁde donors NaSH, GYY4137,
AP67, and AP72 at the concentration of 200μmol/L at
37°C for 16 hours. (C) HUVECs were treated to LDL sam-
ples (50μg/mL) for 8 hours. HO-1 protein expression was
determined by Western blotting. Representative experiment,
n = 3. Relative densitometry was determined with ImageJ
software. (D) Hb (10μmol/L) was incubated with H2O2
(50μmol/L) in the presence or absence of HSX− or decom-
posed sulﬁde donors NaSH, GYY4137, AP67, and AP72
(200μmol/L) at 37°C for 90 minutes. HUVECs were exposed
to the obtained Hb samples for 8 hours and VCAM-1 expres-
sion was determined by Western blotting. Representative
experiment, n = 3. Relative densitometry was determined
with ImageJ software. (Supplementary Materials)
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